Logo image of HCAT

HEALTH CATALYST INC (HCAT) Stock Price, Forecast & Analysis

USA - NASDAQ:HCAT - US42225T1079 - Common Stock

3.23 USD
-0.05 (-1.52%)
Last: 10/31/2025, 8:00:01 PM
3.23 USD
0 (0%)
After Hours: 10/31/2025, 8:00:01 PM

HCAT Key Statistics, Chart & Performance

Key Statistics
Market Cap227.30M
Revenue(TTM)316.09M
Net Income(TTM)-100119000
Shares70.37M
Float66.42M
52 Week High9.24
52 Week Low2.52
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)0.16
PE20.19
Fwd PE7.38
Earnings (Next)11-10 2025-11-10/amc
IPO2019-07-25
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Technology
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Technology


HCAT short term performance overview.The bars show the price performance of HCAT in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20

HCAT long term performance overview.The bars show the price performance of HCAT in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of HCAT is 3.23 USD. In the past month the price increased by 9.12%. In the past year, price decreased by -58.05%.

HEALTH CATALYST INC / HCAT Daily stock chart

HCAT Latest News, Press Relases and Analysis

HCAT Competitors/Peers

The largest stocks on the US markets in the "Health Care Technology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
VEEV VEEVA SYSTEMS INC-CLASS A 39.09 47.73B
DOCS DOXIMITY INC-CLASS A 44.3 12.36B
WAY WAYSTAR HOLDING CORP 26.75 6.84B
HTFL HEARTFLOW INC N/A 3.10B
CERT CERTARA INC 23.73 1.87B
SDGR SCHRODINGER INC N/A 1.55B
TDOC TELADOC HEALTH INC N/A 1.52B
PHR PHREESIA INC N/A 1.36B
GDRX GOODRX HOLDINGS INC-CLASS A 9.63 1.17B
LFMDP LIFEMD INC - LFMD 8 7/8 PERP N/A 1.08B
CTEV CLARITEV CORP N/A 1.07B
CCLDO CARECLOUD INC - CCLD 8 3/4 PERP N/A 891.51M

About HCAT

Company Profile

HCAT logo image Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. The company is headquartered in South Jordan, Utah. The company went IPO on 2019-07-25. The firm's solution comprises its cloud-based data platform, applications, and expertise. Its segments include Technology and Professional Services. The Technology segment includes its data platform, analytics applications and support services and earns primarily from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees. The Professional Services segment is generally a combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver capabilities to its clients to fully configure and utilize the benefits of its technology offerings. Its clients, which are primarily healthcare providers, use its Solution to manage their data, derive analytical insights to operate their organization, and produce measurable clinical, financial, and operational improvements.

Company Info

HEALTH CATALYST INC

10897 South River Front Parkway, #300

South Jordan UTAH 84121 US

CEO: Daniel Burton

Employees: 1500

HCAT Company Website

HCAT Investor Relations

Phone: 18017086800

HEALTH CATALYST INC / HCAT FAQ

What does HCAT do?

Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. The company is headquartered in South Jordan, Utah. The company went IPO on 2019-07-25. The firm's solution comprises its cloud-based data platform, applications, and expertise. Its segments include Technology and Professional Services. The Technology segment includes its data platform, analytics applications and support services and earns primarily from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees. The Professional Services segment is generally a combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver capabilities to its clients to fully configure and utilize the benefits of its technology offerings. Its clients, which are primarily healthcare providers, use its Solution to manage their data, derive analytical insights to operate their organization, and produce measurable clinical, financial, and operational improvements.


What is the current price of HCAT stock?

The current stock price of HCAT is 3.23 USD. The price decreased by -1.52% in the last trading session.


What is the dividend status of HEALTH CATALYST INC?

HCAT does not pay a dividend.


How is the ChartMill rating for HEALTH CATALYST INC?

HCAT has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


What is the expected growth for HCAT stock?

The Revenue of HEALTH CATALYST INC (HCAT) is expected to grow by 1.83% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


What is the employee count for HCAT stock?

HEALTH CATALYST INC (HCAT) currently has 1500 employees.


When does HEALTH CATALYST INC (HCAT) report earnings?

HEALTH CATALYST INC (HCAT) will report earnings on 2025-11-10, after the market close.


HCAT Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to HCAT. When comparing the yearly performance of all stocks, HCAT is a bad performer in the overall market: 93.32% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

HCAT Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to HCAT. HCAT has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

HCAT Financial Highlights

Over the last trailing twelve months HCAT reported a non-GAAP Earnings per Share(EPS) of 0.16. The EPS decreased by -27.27% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -16.25%
ROE -28.81%
Debt/Equity 0.44
Chartmill High Growth Momentum
EPS Q2Q%-66.67%
Sales Q2Q%6.35%
EPS 1Y (TTM)-27.27%
Revenue 1Y (TTM)5.55%

HCAT Forecast & Estimates

18 analysts have analysed HCAT and the average price target is 4.53 USD. This implies a price increase of 40.35% is expected in the next year compared to the current price of 3.23.

For the next year, analysts expect an EPS growth of -19.86% and a revenue growth 1.83% for HCAT


Analysts
Analysts73.33
Price Target4.53 (40.25%)
EPS Next Y-19.86%
Revenue Next Year1.83%

HCAT Ownership

Ownership
Inst Owners78.61%
Ins Owners3.42%
Short Float %9.99%
Short Ratio10.28